Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or... – Recovery or purification
Reexamination Certificate
2007-11-13
2007-11-13
Campell, Bruce R. (Department: 1648)
Chemistry: molecular biology and microbiology
Virus or bacteriophage, except for viral vector or...
Recovery or purification
C435S235100, C435S456000, C435S463000, C435S464000, C435S466000
Reexamination Certificate
active
10046671
ABSTRACT:
The invention relates to Infectious Bursal Disease Virus (“IBDV”) and vaccines therefor. Provided are infectious recombinant Infectious Bursal Disease Virus (“rIBDV”) essentially incapable of growing in a cell that is not derived from a bursa cell, or an infectious rIBDV having retained at least part of the very virulent characteristics of a very virulent Infectious Bursal Disease Virus (“vvIBDV”).
REFERENCES:
patent: 4824668 (1989-04-01), Melchior, Jr. et al.
patent: 5788970 (1998-08-01), Vakharia et al.
patent: 5830723 (1998-11-01), Foster et al.
patent: 5871744 (1999-02-01), Vakharia et al.
patent: 6017759 (2000-01-01), Vakharia et al.
patent: WO95/26196 (1995-10-01), None
patent: WO98/06827 (1998-02-01), None
patent: WO98/09646 (1998-03-01), None
patent: WO 01/04319 (2001-01-01), None
Muller, H. and Becht, H. “Biosynthesis of virus-specific proteins in cells infected with infectious bursal disease virus and their significance as structural elements for infectious virus and incomplete particles” J. Virology vol. 44(1982), pp. 384-392.
Mundt E. “Tissue culture infectivity of different strains of infectious busal disease virus is determined by distinct amino acid in V2” J. Gen. Virology vol. 80(1999), pp. 2067-2076.
PCT International Search Report, PCT/NL00/00493 dated Oct. 30, 2000.
Lim et al., Adaptation of Very Virulent Infectious Bursal Disease Virus to Chicken Embryonic Fibroblasts by Site-Directed Mutagenesis of Residues 279 and 284 of Viral Coat Protein VP2, Journal of Virology, Apr. 1999, pp. 2854-2862, vol. 73, No. 4.
Muller et al., Biosynthesis of Virus-Specific Proteins in Cells Infected with Infectious Bursal Disease Virus and Their Significance as Structural Elements for Infectious Virus and Incomplete Particles, Journal of Virology, Oct. 1982, pp. 384-392, vol. 44, No. 1.
Mundt, Tissue culture infectivity of different strains of infectious bursal disease virus is determined by distinct amino acids in VP2, Journal of General Virology, 1999, pp. 2067-2076, vol. 80.
PCT International Search Report, PCT/US95/03772, dated Jul. 19, 1995, 3 pages.
PCT International Search Report, PCT/US97/14391, dated Feb. 13, 1998, 2 pages.
Boot Hendrik Johannis
Peeters Bernardus Petrus H.
ter Huurne Anna Agnes H. M.
Campell Bruce R.
ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V.
Peng Bo
TraskBritt
LandOfFree
Mosaic infectious bursal disease virus vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mosaic infectious bursal disease virus vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mosaic infectious bursal disease virus vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3847805